Home » If a patient of advanced NSCLC, no targetable driver mutation is found and PD-L1 expression is ≥ 50%, which of the following will be the best treatment approach
Cancer MCQs

If a patient of advanced NSCLC, no targetable driver mutation is found and PD-L1 expression is ≥ 50%, which of the following will be the best treatment approach

January 11, 2022
0 Views
If a patient of advanced NSCLC, no targetable driver mutation is found and PD-L1 expression is ≥ 50%, which of the following will be the best treatment approach

Q. If a patient of advanced NSCLC, no targetable driver mutation is found and PD-L1 expression is ≥ 50%, which of the following will be the best treatment approach :

A.            Pembrolizumab

B.            Pembrolizumab plus single agent platinum

C.            Pembrolizumab plus platinum based doublet chemotherapy

D.            Platinum based doublet chemotherapy

Answer: Pembrolizumab

Take Mock Tests

Government Schemes Mock Test Start Test!
Political Science Mock Test – 42 Start Test
History Test – 190 Start Test
Quantitative Aptitude Test Start Test!
Data Interpretation - Mock Test Start Test!
General Awareness - Mock Test Start Test!
Reasoning Ability - Mock Test Start Test!

Related Articles
We will be happy to hear your thoughts

Leave a reply

Gkseries.com
Logo
Register New Account